title: Highly preferential association of NonF508del CF mutations with the M470 allele.
abstract: BACKGROUND
  On the basis of previous findings on random individuals, we hypothesized a preferential association of CF causing mutations with the M allele of the M470V polymorphic site of the CFTR gene.
  
  
  METHODS
  We have determined the M/V-CF mutation haplotype in a series of 201 North East Italian and 73 Czech CF patients who were not F508del homozygotes, as F508del was already known to be fully associated with the M allele.
  
  
  RESULTS
  Out of 358 not F508del CF genes, 84 carried the V allele and 274 the less common M allele. In the N-E Italian population, MM subjects have a risk of carrying a CF causing mutation 6.9x greater than VV subjects when F508del is excluded and 15.4x when F508del is included. In the Czech population a similar, although less pronounced, association is observed.
  
  
  CONCLUSIONS
  Besides the possible biological significance of this association, the possibility of exploiting it for a pilot screening program has been explored in a local North East Italian population for which CF patients were characterized for their CF mutation. General M470V genotyping followed by common CF mutation screening limited to couples in which each partner carries at least one M allele would need testing only 39% of the couples, which contribute 89% of the total risk, with a cost benefit.
authors.affiliation: Department of Biology, University of Roma-Tor Vergata, Via della Ricerca Scientifica, s.n.c. 00133 Rome, and Cystic Fibrosis Centre, Hospital of Verona, Italy. bianca.ciminelli@uniroma2.it
authors.forename: B M
authors.initials: BM
authors.lastname: Ciminelli
authors.forename: A
authors.initials: A
authors.lastname: Bonizzato
authors.forename: C
authors.initials: C
authors.lastname: Bombieri
authors.forename: F
authors.initials: F
authors.lastname: Pompei
authors.forename: M
authors.initials: M
authors.lastname: Gabaldo
authors.forename: C
authors.initials: C
authors.lastname: Ciccacci
authors.forename: A
authors.initials: A
authors.lastname: Begnini
authors.forename: A
authors.initials: A
authors.lastname: Holubova
authors.forename: P
authors.initials: P
authors.lastname: Zorzi
authors.forename: T
authors.initials: T
authors.lastname: Piskackova
authors.forename: M
authors.initials: M
authors.lastname: Macek
authors.forename: C
authors.initials: C
authors.lastname: Castellani
authors.forename: G
authors.initials: G
authors.lastname: Modiano
authors.forename: P F
authors.initials: PF
authors.lastname: Pignatti
mesh_terms: D003550:Cystic Fibrosis / Q000208:ethnology / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D018153:Czech Republic / Q000208:ethnology; D004252:DNA Mutational Analysis; D005260:Female; D005787:Gene Frequency / Q000235:genetics; D005820:Genetic Testing / Q000379:methods*; D006579:Heterozygote; D006801:Humans; D007558:Italy / Q000208:ethnology; D008297:Male; D009154:Mutation; D010865:Pilot Projects; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012306:Risk; D044465:White People / Q000235:genetics*
chemical_list: C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator